News Jun 16, 2014
Thermo Fisher Scientific announced that its San Jose, California facility has registered with the U.S. Food and Drug Administration (FDA) as a medical device establishment.
“Last year we achieved ISO 13485 certification for the San Jose site, and this FDA registration is the next major milestone in our ongoing initiative to develop Class 1 mass spectrometry-based instruments for the clinical market,” said Dan Shine, president, chromatography and mass spectrometry, Thermo Fisher Scientific.
However, currently available technologies for diagnosing AD are limited because they involve expensive machinery and invasive or inconvenient procedures. Now, a new study hints at a novel way of diagnosing AD in a much simpler way – collecting and analyzing specific proteins in nasal discharge samples.
In recent years, the number of people affected by coeliac disease, wheat allergy or gluten or wheat sensitivity has risen sharply. But why is this the case? Could it be that modern wheat varieties contain more immunoreactive protein than in the past? Recent results are helping to answer this question.
READ MORELike what you just read? You can find similar content on the communities below.
DiagnosticsTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
